Yutaro Yamamoto, Camila Fabbri, Daiki Okuhara, Rina Takagi, Yuna Kawabata, Takuto Katayama, Mitsuhiro Iyori, Ammar A. Hasyim, Akihiko Sakamoto, Hiroaki Mizukami, et al. A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study. Frontiers in Immunology. 2024. 15. 1372584
Sitti Nurisyah, Mitsuhiro Iyori, Ammar A. Hasyim, Akihiko Sakamoto, Hinata Hashimoto, Kyouhei Yamagata, Saya Yamauchi, Khaeriah Amru, Kartika H. Zainal, Irfan Idris, et al. Comparison between neutralization capacity of antibodies elicited by COVID-19 natural infection and vaccination in Indonesia: A prospective cohort. Antibodies. 2023. 12. 3. 60
Satomi Sahashi, Kazuyuki Shimada, Yusuke Takagi, Tomohiro Aoki, Shunsuke Kunou, Akihiko Sakamoto, Atsushi Murase, Katsuya Furukawa, Yusuke Kagaya, Yusuke Yamaga, et al. Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice. International Journal of Hematology. 2023. 118. 221-230
P. falciparum-P. vivax bivalent vaccine development using LC16m8Δ/AAV viral vectors platform achieves sterile protection and transmission blocking
(ASTMH 2023 Annual Meeting 2023)
Humoral immune responses to the central repeat region of PfCSP induced by a viral-vectored plasmodium falciparum vaccine play critical roles in protection in a murine model
(ASTMH 2023 Annual Meeting 2023)